큐리진

kor kor

큐리진 큐리진

kor kor
Pipelines
  • Research
  • Production
  • Pre-clinical
  • Clinical trials

Candidate

  • Target validation
  • product optimization
  • POC
  • in vivo efficacy
  • Process development
  • GMP production
  • GLP-tox
  • IND
  • phase 1
CA102
  • Target Gene:
  • mTOR & STAT3

[Investigational Indications]

▪Bladder Cancer

▪Pancreatic Cancer

CA103
  • Target Gene:
  • mTOR & AR

[Investigational Indications]

▪Prostate Cancer

▪Benign prostate hyperplasia

CA106-T
  • Target Genes:
  • MYC & BCL-2

[Investigational Indications]

▪Lung cancer

▪Ovarian cancer

Csi103
  • Target Genes:
  • N.D /N.D.

[Investigational Indications]

▪Primary Hyperoxaluria 1

▪Liver fibrosis/cirrhosis

Csi107
  • Target Genes:
  • N.D / N.D.

[Investigation Indications]

▪Pulmonary Fibrosis

▪Cystic Fibrosis

CA102

GLP-tox

  • Target Gene:
  • mTOR & STAT3
  • [Investigational Indications]
  • ▪Bladder Cancer
  • ▪Pancreatic Cancer
CA103

POC

  • Target Gene:
  • mTOR & AR
  • [Investigational Indications]
  • ▪Prostate Cancer
  • ▪Benign prostate hyperplasia
CA106-T

POC

  • Target Genes:
  • MYC & BCL-2
  • [Investigational Indications]
  • ▪Lung cancer
  • ▪Ovarian cancer
Csi103

Target validation

  • Target Genes:
  • N.D /N.D.
  • [Investigational Indications]
  • ▪Primary Hyperoxaluria 1
  • ▪Liver fibrosis/cirrhosis
Csi107

Target validation

  • Target Genes:
  • N.D / N.D.
  • [Investigation Indications]
  • ▪Pulmonary Fibrosis
  • ▪Cystic Fibrosis